Cargando…
Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
Background: Programmed death-ligand 1 (PD-L1) is expressed not only on some cancer cells, but also on the outer surface of placental syncytiotrophoblasts, which is assumed to induce maternal immune tolerance to fetal tissue via programmed death-1 (PD-1) receptors on T cells. Recently, levels of solu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387906/ https://www.ncbi.nlm.nih.gov/pubmed/30833943 http://dx.doi.org/10.3389/fimmu.2019.00086 |
_version_ | 1783397658806714368 |
---|---|
author | Okuyama, Mai Mezawa, Hidetoshi Kawai, Toshinao Urashima, Mitsuyoshi |
author_facet | Okuyama, Mai Mezawa, Hidetoshi Kawai, Toshinao Urashima, Mitsuyoshi |
author_sort | Okuyama, Mai |
collection | PubMed |
description | Background: Programmed death-ligand 1 (PD-L1) is expressed not only on some cancer cells, but also on the outer surface of placental syncytiotrophoblasts, which is assumed to induce maternal immune tolerance to fetal tissue via programmed death-1 (PD-1) receptors on T cells. Recently, levels of soluble forms of PD-L1 (sPD-L1) were reported to be higher in the serum of pregnant women (PW) than in non-pregnant women (non-PW). However, there have been no reports of the functional significance of PW's serum containing high sPD-L1 levels. Therefore, the aim of the present study was to clarify the role of sPD-L1 in the sera of PW as an immunosuppressive molecule by in vitro assays. Methods: As a post-hoc analysis of our previous cohort study, 330 pairs of serum from PW during the third trimester and cord blood (CB) from paired offspring without major complications were examined. Serum levels of sPD-L1 and sPD-1 were measured by ELISA. On mixed lymphocyte culture (MLC), (3)H-thymidine uptakes in the presence of PW's, offspring's, or non-PW's serum were compared. Peripheral blood mononuclear cells (PBMCs) were cultured in the presence of PW's serum stimulated with PHA, and then cytokine levels were measured in supernatants by multiple cytokine analysis with or without anti-PD-L1blocking antibody. Results: The median sPD-L1 level was 8.3- and 6.9-fold higher in PW than in offspring and non-PW, respectively, whereas sPD-1 levels were lower in PW and offspring than in non-PW. On MLC, (3)H-thymidine uptake in the presence of autoantigen was strongly reduced by co-culture with serum of both PW and offspring, compared with serum of non-PW. In contrast, uptake in the presence of alloantigen was moderately inhibited by PW's serum, whereas it was less suppressed by offspring's serum, compared with non-PW's serum. In the culture of PBMCs, tumor necrosis factor-α, interferon gamma, interleukin (IL)-2, and IL-4 levels were significantly higher in the presence of anti-PD-L1 blocking antibody than in culture not treated with antibody (all P < 0.05) or culture treated with isotype control antibody (all P < 0.05). Conclusion: The levels of sPD-L1 are elevated in PW's serum, which may, at least in part, suppress maternal immunity. |
format | Online Article Text |
id | pubmed-6387906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63879062019-03-04 Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction Okuyama, Mai Mezawa, Hidetoshi Kawai, Toshinao Urashima, Mitsuyoshi Front Immunol Immunology Background: Programmed death-ligand 1 (PD-L1) is expressed not only on some cancer cells, but also on the outer surface of placental syncytiotrophoblasts, which is assumed to induce maternal immune tolerance to fetal tissue via programmed death-1 (PD-1) receptors on T cells. Recently, levels of soluble forms of PD-L1 (sPD-L1) were reported to be higher in the serum of pregnant women (PW) than in non-pregnant women (non-PW). However, there have been no reports of the functional significance of PW's serum containing high sPD-L1 levels. Therefore, the aim of the present study was to clarify the role of sPD-L1 in the sera of PW as an immunosuppressive molecule by in vitro assays. Methods: As a post-hoc analysis of our previous cohort study, 330 pairs of serum from PW during the third trimester and cord blood (CB) from paired offspring without major complications were examined. Serum levels of sPD-L1 and sPD-1 were measured by ELISA. On mixed lymphocyte culture (MLC), (3)H-thymidine uptakes in the presence of PW's, offspring's, or non-PW's serum were compared. Peripheral blood mononuclear cells (PBMCs) were cultured in the presence of PW's serum stimulated with PHA, and then cytokine levels were measured in supernatants by multiple cytokine analysis with or without anti-PD-L1blocking antibody. Results: The median sPD-L1 level was 8.3- and 6.9-fold higher in PW than in offspring and non-PW, respectively, whereas sPD-1 levels were lower in PW and offspring than in non-PW. On MLC, (3)H-thymidine uptake in the presence of autoantigen was strongly reduced by co-culture with serum of both PW and offspring, compared with serum of non-PW. In contrast, uptake in the presence of alloantigen was moderately inhibited by PW's serum, whereas it was less suppressed by offspring's serum, compared with non-PW's serum. In the culture of PBMCs, tumor necrosis factor-α, interferon gamma, interleukin (IL)-2, and IL-4 levels were significantly higher in the presence of anti-PD-L1 blocking antibody than in culture not treated with antibody (all P < 0.05) or culture treated with isotype control antibody (all P < 0.05). Conclusion: The levels of sPD-L1 are elevated in PW's serum, which may, at least in part, suppress maternal immunity. Frontiers Media S.A. 2019-02-18 /pmc/articles/PMC6387906/ /pubmed/30833943 http://dx.doi.org/10.3389/fimmu.2019.00086 Text en Copyright © 2019 Okuyama, Mezawa, Kawai and Urashima. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Okuyama, Mai Mezawa, Hidetoshi Kawai, Toshinao Urashima, Mitsuyoshi Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction |
title | Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction |
title_full | Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction |
title_fullStr | Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction |
title_full_unstemmed | Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction |
title_short | Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction |
title_sort | elevated soluble pd-l1 in pregnant women's serum suppresses the immune reaction |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387906/ https://www.ncbi.nlm.nih.gov/pubmed/30833943 http://dx.doi.org/10.3389/fimmu.2019.00086 |
work_keys_str_mv | AT okuyamamai elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction AT mezawahidetoshi elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction AT kawaitoshinao elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction AT urashimamitsuyoshi elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction |